Evaluation of zinc (II) chelators for inhibiting p53-mediated apoptosis.
about
Degradation of mutant p53H175 protein by Zn(II) through autophagy.TAp73 promotes anabolismRadioprotective Agents: Strategies and Translational Advances.Resveratrol-zinc combination for prostate cancer management.Checkpoint kinase 2 is dispensable for regulation of the p53 response but is required for G2/M arrest and cell survival in cells with p53 defects under heat stress.
P2860
Evaluation of zinc (II) chelators for inhibiting p53-mediated apoptosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Evaluation of zinc (II) chelators for inhibiting p53-mediated apoptosis.
@en
Evaluation of zinc
@nl
type
label
Evaluation of zinc (II) chelators for inhibiting p53-mediated apoptosis.
@en
Evaluation of zinc
@nl
prefLabel
Evaluation of zinc (II) chelators for inhibiting p53-mediated apoptosis.
@en
Evaluation of zinc
@nl
P2093
P2860
P356
P1433
P1476
Evaluation of zinc (II) chelators for inhibiting p53-mediated apoptosis.
@en
P2093
Akinori Morita
Atsushi Enomoto
Haruna Okazaki
Ippei Takahashi
Kaoru Tanaka
Kengo Hanaya
Masahiko Ikekita
Mitsuru Nenoi
P2860
P304
P356
10.18632/ONCOTARGET.1535
P407
P577
2013-12-01T00:00:00Z